2008
DOI: 10.1007/s00213-008-1267-8
|View full text |Cite
|
Sign up to set email alerts
|

Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study

Abstract: Acute systemic ethanol administration induced a dose- and time-dependent increase in beta-endorphin and dynorphin A1-8 release at the level of the CeA, which may be involved in ethanol consumption.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
90
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 84 publications
(92 citation statements)
references
References 54 publications
2
90
0
Order By: Relevance
“…We and others have previously shown that acute ethanol administration enhances GABA release at CeA synapses from rats and mice (Roberto et al, 2003;Nie et al, 2004;Kang-Park et al, 2007). In addition, our previous physiologic studies indicate that acute ethanol administration induces release of such neuropeptides as endogenous opioids and CRF in CeA (Nie et al, 2004;Lam et al, 2008), and these peptides may further modulate GABA release (Nie et al, 2004;Kang-Park et al, 2007Roberto et al, 2010). We hypothesize that acute ethanol releases dynorphin in CeA that acts at presynaptic KORs by decreasing GABA release and partially ameliorating the overall effect of ethanol on such release.…”
Section: Methodsmentioning
confidence: 84%
“…We and others have previously shown that acute ethanol administration enhances GABA release at CeA synapses from rats and mice (Roberto et al, 2003;Nie et al, 2004;Kang-Park et al, 2007). In addition, our previous physiologic studies indicate that acute ethanol administration induces release of such neuropeptides as endogenous opioids and CRF in CeA (Nie et al, 2004;Lam et al, 2008), and these peptides may further modulate GABA release (Nie et al, 2004;Kang-Park et al, 2007Roberto et al, 2010). We hypothesize that acute ethanol releases dynorphin in CeA that acts at presynaptic KORs by decreasing GABA release and partially ameliorating the overall effect of ethanol on such release.…”
Section: Methodsmentioning
confidence: 84%
“…Because changes were observed at concentrations as low as those of endogenous m-opioids in the rat brain (Lam et al, 2008), these changes might reflect the modulation of SWRs by endogenous opioids. In the hippocampus, MORs are almost exclusively located on GABAergic inhibitory interneurons (Drake and Milner, 2002) and opioid agonists modulate inhibition (Nicoll et al, 1980;Lupica, 1995) and increase the excitability of the pyramidal cells (Zieglgansberger et al, 1979;Masukawa and Prince, 1982;Swearengen and Chavkin, 1987).…”
Section: Interpretation Of Drug Effects -Implications For the Mechanimentioning
confidence: 98%
“…We then studied the effects of the three MOR agonists, morphine, DAMGO and fentanyl, used in a wide range of concentrations (1 nM-10 mM ), which includes concentrations similar to brain extracellular levels of endogenous opioids and clinically relevant concentrations of exogenous opioid agonists. Thus morphine, fentanyl and DAMGO were applied at concentrations (10 -9 to 10 -5 M) that included the nanomole regime covering the range of clinically relevant brain concentrations (Bouw et al, 2001), the opioid concentrations found in the cerebrospinal fluid (Bernards et al, 2003) or the plasma/serum (Veselis et al, 1994;Klepstad et al, 2003;Gunnar et al, 2004;Solassol et al, 2005) as well as the extracellular levels of endogenous brain opioids (~1 to 10 nM) (Lam et al, 2008).…”
Section: Figurementioning
confidence: 99%
“…These data are consistent with preclinical studies showing that single intraperitoneal injection of either ethanol or amphetamine lead to increases in microdialysate b-endorphin concentrations taken from the rat nucleus accumbens 12,13 and the central nucleus of the amygdala. 14 However, the findings of Colasanti et al 11 failed to be replicated by another group using intravenous amphetamine administration; 15 therefore, the sensitivity of [ 11 C]carfentanil to EOP release after amphetamine challenge warrants further investigation. In addition to [ 11 C]carfentanil's sensitivity to EOP release, various preclinical [16][17][18] and clinical 5,8 paradigms suggest that [ 11 C]diprenorphine may also be susceptible to EOP release; however, the ability of amphetamine to reduce [ 11 C]diprenorphine binding has not yet been tested.…”
Section: Introductionmentioning
confidence: 99%